연구성과로 돌아가기
JCR 2020 저널 목록 (1432 / 1974)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Case Reports in Dentistry | HINDAWI LTD | 2090-6447 | 2090-6455 | ESCI | DENTISTRY, ORAL SURGERY & MEDICINE | 770 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.36 | 113/151 | Q3 | 25.50 | 0.001 | 0.210 | 0.174 | Q3 | 133 | 90.2% | 4.6 | 9.3 | 120 | 98.1% | 2025-07-04 04:23:41 | 바로가기 |
| Case Reports in Dermatology | KARGER | 1662-6567 | 1662-6567 | ESCI | DERMATOLOGY | 517 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.35 | 71/90 | Q4 | 21.67 | 0.001 | 0.141 | 0.214 | Q2 | 45 | 86.7% | 5.2 | 8.1 | 39 | 98.7% | 2025-07-04 04:23:42 | 바로가기 |
| Case Reports in Endocrinology | HINDAWI LTD | 2090-6501 | 2090-651X | ESCI | ENDOCRINOLOGY & METABOLISM | 380 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.20 | 157/180 | Q4 | 13.06 | 0.001 | 0.136 | 0.233 | Q3 | 71 | 81.7% | 3.5 | 7.5 | 58 | 97.0% | 2025-07-04 04:23:52 | 바로가기 |
| Case Reports in Gastrointestinal Medicine | HINDAWI LTD | 2090-6528 | 2090-6536 | ESCI | GASTROENTEROLOGY & HEPATOLOGY | 363 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.12 | 122/131 | Q4 | 7.25 | 0.001 | 0.134 | 0.182 | Q4 | 59 | 91.5% | 3.8 | 9.1 | 54 | 98.6% | 2025-07-04 04:24:12 | 바로가기 |
| Case Reports in Hematology | HINDAWI LTD | 2090-6560 | 2090-6579 | ESCI | HEMATOLOGY | 537 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.16 | 83/93 | Q4 | 11.29 | 0.001 | 0.200 | 0.211 | Q3 | 76 | 79.0% | 3.5 | 7.9 | 60 | 97.5% | 2025-07-04 04:24:18 | 바로가기 |
| Case Reports in Immunology | HINDAWI LTD | 2090-6609 | 2090-6617 | ESCI | IMMUNOLOGY | 81 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.23 | 168/177 | Q4 | 5.37 | 0.000 | 0.034 | 0.274 | Q3 | 13 | 92.3% | N/A | 8.7 | 12 | 100.0% | 2025-07-04 04:24:26 | 바로가기 |
| Case Reports in Infectious Diseases | HINDAWI LTD | 2090-6625 | 2090-6633 | ESCI | INFECTIOUS DISEASES | 587 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.20 | 106/118 | Q4 | 10.59 | 0.001 | 0.241 | 0.226 | Q4 | 103 | 84.5% | 4.1 | 9.2 | 87 | 99.7% | 2025-07-04 04:24:27 | 바로가기 |
| Case Reports in Medicine | HINDAWI LTD | 1687-9627 | 1687-9635 | ESCI | MEDICINE, GENERAL & INTERNAL | 1,399 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.20 | 192/315 | Q3 | 39.21 | 0.001 | 0.271 | 0.191 | Q2 | 113 | 84.1% | 6.9 | 8.1 | 95 | 100.0% | 2025-07-04 04:24:51 | 바로가기 |
| Case Reports in Nephrology and Dialysis | KARGER | 2296-9705 | 2296-9705 | ESCI | UROLOGY & NEPHROLOGY | 163 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.20 | 102/119 | Q4 | 14.71 | 0.000 | 0.062 | 0.216 | Q3 | 23 | 87.0% | 4.6 | 9.3 | 20 | 100.0% | 2025-07-04 04:26:02 | 바로가기 |
| Case Reports in Neurological Medicine | HINDAWI LTD | 2090-6668 | 2090-6676 | ESCI | CLINICAL NEUROLOGY | 565 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.18 | 235/255 | Q4 | 8.04 | 0.001 | 0.204 | 0.267 | Q3 | 51 | 90.2% | 4.7 | 9.1 | 46 | 98.2% | 2025-07-04 04:23:26 | 바로가기 |
| Case Reports in Neurology | KARGER | N/A | 1662-680X | ESCI | CLINICAL NEUROLOGY | 382 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.19 | 234/255 | Q4 | 8.43 | 0.001 | 0.118 | 0.216 | Q3 | 107 | 94.4% | 5.0 | 8.8 | 101 | 100.0% | 2025-07-04 04:23:26 | 바로가기 |
| Case Reports in Oncological Medicine | HINDAWI LTD | 2090-6706 | 2090-6714 | ESCI | ONCOLOGY | 527 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.15 | 282/310 | Q4 | 9.19 | 0.001 | 0.169 | 0.202 | Q3 | 72 | 79.2% | 5.3 | 7.7 | 57 | 99.6% | 2025-07-04 04:25:06 | 바로가기 |
| Case Reports in Oncology | KARGER | 1662-6575 | 1662-6575 | ESCI | ONCOLOGY | 1,081 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.20 | 272/310 | Q4 | 12.42 | 0.002 | 0.362 | 0.255 | Q3 | 251 | 92.8% | 3.9 | 7.5 | 233 | 100.0% | 2025-07-04 04:25:06 | 바로가기 |
| Case Reports in Ophthalmological Medicine | HINDAWI LTD | 2090-6722 | N/A | ESCI | OPHTHALMOLOGY | 284 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.18 | 83/89 | Q4 | 7.30 | 0.000 | 0.079 | 0.137 | Q4 | 60 | 96.7% | 5.6 | 9.9 | 58 | 96.5% | 2025-07-04 04:25:08 | 바로가기 |
| Case Reports in Ophthalmology | KARGER | 1663-2699 | N/A | ESCI | OPHTHALMOLOGY | 501 | N/A | N/A | 100.0 | N/A | N/A | N/A | N/A | N/A | N/A | 0.24 | 80/89 | Q4 | 10.67 | 0.001 | 0.143 | 0.154 | Q3 | 99 | 98.0% | 5.2 | 9.5 | 97 | 100.0% | 2025-07-04 04:25:08 | 바로가기 |
페이지 이동: